Developer of genomics and bioinformatics platform designed to unify research over democratizing access to omics data. The company's platform offers reproducible and easy-to-share genomics analysis in a single click provides integration with free open-source analysis alongside a marketplace of proprietary alternatives and gives access to visualization of large data sets associated with human genome sequencing, enabling researchers to run complex analyses and generate meaningful insights and secure research over distributed big data.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
Developer of a research platform designed to automate and improve administrative tasks throughout the research life-cycle. The company's platform leverages artificial intelligence to offer real-time data capture and reporting, compliance and security, automated document creation and filing, customization and branding, enabling medical researchers to streamline clinical operations and patient engagement easily.
Developer of a personal DNA cloud data upload application designed to make people connect data with insights, products, and research. The company's platform allows members to upload their raw data files and discover their identities and traits through intuitive visualization and scientific-educational content, enabling members to learn about their DNA data while ensuring ultimate transparency.
Developer of a biotechnology platform designed to combine genomic and phenotypic information to accelerate the understanding of human health. The company's platform addresses the age-related decline in endogenous stem cell function and concentrates on cancer, diabetes and obesity, heart and liver diseases and dementia by combining deoxyribonucleic acid sequencing and expert analysis with machine learning, enabling people to shape their health and shift the practice of medicine from reactive to proactive technologies.